{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T08:24:00Z","timestamp":1683102240733},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1985,1]]},"DOI":"10.1007\/bf01644219","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T07:33:08Z","timestamp":1115451188000},"page":"S50-S55","source":"Crossref","is-referenced-by-count":7,"title":["Bone and joint infections caused by gram-positive bacteria: Treatment with cefotaxime"],"prefix":"10.1007","volume":"13","author":[{"given":"J.","family":"LeFrock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/AAC.14.5.749","volume":"14","author":"Y. A. Chabbert","year":"1978","unstructured":"Chabbert, Y. A., Lutz, A. J. HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity. Antimicrob. Agents Chemother. 14 (1978) 749\u2013754.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/AAC.14.3.322","volume":"14","author":"K. P. Fu","year":"1978","unstructured":"Fu, K. P., Neu, H. C. Beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Antimicrob. Agents Chemother. 14 (1978) 322\u2013326.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/AAC.15.2.273","volume":"15","author":"H. C. Neu","year":"1979","unstructured":"Neu, H. C., Aswapokee, N., Aswapokee, P., Fu, K. P. HR-756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 15 (1979) 273\u2013381.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01641308","volume":"7","author":"M. Stephens","year":"1979","unstructured":"Stephens, M., Potten, M., Bint, A. V. The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides. Infection 7 (1979) 109\u2013112.","journal-title":"Infection"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jac\/4.5.437","volume":"4","author":"J. M. T. Hamilton-Miller","year":"1978","unstructured":"Hamilton-Miller, J. M. T., Brumfitt, W., Reynolds, A. V. Cefotaxime (HR-756), a new cephalosporin with exceptional broad-spectrum activityin vitro. J. Antimicrob. Chemother. 4 (1978) 437\u2013444.","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl.","key":"CR6","first-page":"103","volume":"11","author":"J. T. Mader","year":"1981","unstructured":"Mader, J. T., Hyams, K. C., Reinarz, J. A. Treatment of osteomyelitis with cefotaxime. Drug Ther. 11 Suppl. (1981) 103\u2013108.","journal-title":"Drug Ther."},{"issue":"Suppl.","key":"CR7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/clinids\/4.Supplement_2.S465","volume":"4","author":"J. L. LeFrock","year":"1982","unstructured":"LeFrock, J. L., Carr, B. B. Clinical experience with cefotaxime in the treatment of serious bone and joint infections. Rev. Infect. Dis. 4 Suppl. (1982) 465\u2013472.","journal-title":"Rev. Infect. Dis."},{"key":"CR8","volume-title":"Proposed reference dilution procedure for antimicrobic susceptibility testing of anaerobic bacteria. Provisional Standard, PSM-11","author":"National Committee for Clinical Laboratory Standards","year":"1979","unstructured":"National Committee for Clinical Laboratory Standards Proposed reference dilution procedure for antimicrobic susceptibility testing of anaerobic bacteria. Provisional Standard, PSM-11. National Committee for Clinical Laboratory Standards, Villanova, PA, 1979."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-83-5-671","volume":"83","author":"M. DiCato","year":"1975","unstructured":"DiCato, M., Ellman, L. Cephalothin-induced granulocytopenia. Ann. Intern. Med. 83 (1975) 671\u2013672.","journal-title":"Ann. Intern. Med."},{"key":"CR10","first-page":"272","volume":"3","author":"A. Davis","year":"1963","unstructured":"Davis, A., Seligman, S. J., Hewitt, W. L., Finegold, S. M. Neutropenic reaction to cephalothin in therapy. Antimicrob. Agents Chemother. 3 (1963) 272\u2013277.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR11","unstructured":"Mader, J. T., Shannon, C. R., Cierney, G., Reinarz, J. A.: Treatment of acute and chronic osteomyelitis with ceftizoxime (FK-749). Rev. Infect. Dis. 1985 (in print)."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.1976.03270090042027","volume":"236","author":"J. F. Tures","year":"1976","unstructured":"Tures, J. F., Townsend, W. F., Rose, H. D. Cephalosporin-associated pseudomembranous colitis. J. Am. Med. Assoc. 236 (1976) 948\u2013949.","journal-title":"J. Am. Med. Assoc."},{"issue":"Suppl. A","key":"CR13","doi-asserted-by":"crossref","first-page":"A53","DOI":"10.1093\/jac\/7.suppl_A.53","volume":"7","author":"S. P. Borriello","year":"1981","unstructured":"Borriello, S. P., Larson, H. E. Antibiotic and pseudomembranous colitis. J. Antimicrob. Chemother. 7 Suppl. A (1981) A53-A62.","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01644219\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T12:30:39Z","timestamp":1557232239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01644219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":13,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["BF01644219"],"URL":"https:\/\/doi.org\/10.1007\/bf01644219","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]}}}